As of September 10, 2024, Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF has gone out of business. Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is an exchange traded fund launched and managed by Amplify Investments LLC. It is co-managed by Tidal Investments LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating in companies that perform research, development, and commercialization of treatments or vaccines for infectious diseases or engage in the research, development, manufacturing, and provision of biological tests for patients. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the Prime Treatments, Testing and Advancements Index, by using full replication technique. Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF was formed on June 17, 2020 and is domiciled in the United States.